Florida Daily – June 13
“I also worked closely with Moffitt Cancer Center to make sure our veterans have access to the highest quality cancer care and cutting-edge clinical trials,” Spano added.
Retrofit Magazine – June 13
The leading institutional projects were the $250 million second phase of the Kaiser Permanente Hospital in Sacramento, Calif., and the $150 million Moffitt Cancer Center Hospital in Tampa, Fla.
OncLive – June 12
While ramucirumab is currently FDA approved in combination with paclitaxel in the second-line setting, many patients are unable to tolerate the regimen as paclitaxel is also neurotoxic, said Mehta, a gastrointestinal medical oncologist at Moffitt Cancer Center.
HealthDay – June 12
"This is a fascinating study," said Dr. Zeynep Eroglu, a skin cancer specialist at Moffitt Cancer Center, in Tampa, Fla.
MedPage Today – June 12
For example, researchers at Moffitt Cancer Center in Tampa, Florida, analyzed the response to abemaciclib-based therapy in patients with HR+/HER2- metastatic breast cancer who had prior exposure to palbociclib.
The USF Oracle- June 11
This year, Castor is playing on behalf of Theresa Jean-Pierre Coy, otherwise known as Tenacious Theresa, who was diagnosed with breast cancer in 2017 at age 37. Jean-Pierre Coy was most recently the president of the George Edgecomb Bar Association and together with the George Edgecomb Society, they raised $120,000 for cancer research at Moffitt Cancer Center.
Prevention- June 11
Burkitt lymphoma is “very aggressive” form of lymphoma, says Julio Chavez, MD, assistant member of Moffitt Cancer Center’s Malignant Hematology Department.
Tampa Bay Business Journal - June 11
Lawman said they have treated over 130 pet animals with naturally occurring cancers and have started the first Phase 1 trial on humans at Moffitt Cancer Center. By end of this year, Morphogenesis is hoping to open its Phase 2 study.
The Villages Daily Sun - June 10
Many don’t feel as comfortable talking about colorectal cancer prevention as they do other forms, said Dr. Bryan McIver, deputy physician-in-chief at Moffitt Cancer Center.
Yahoo Finance - June 10
Rami Komrokji, M.D., Clinical Director, Malignant Hematology Department Lead Clinical Investigator, Moffitt Cancer Center, Tampa, Florida, will review analyses presented at EHA of the overall survival (OS) data from relapsed/refractory myelofibrosis (MF) patients treated with 9.4 mg/kg of imetelstat in the IMbark Phase 2 clinical trial, compared to real-world data (RWD) from closely-matched MF patients who had discontinued treatment from a JAK inhibitor (JAKi) and were subsequently treated with best available therapy.
Oncology Times - June 5
Researchers from Moffitt Cancer Center and Dana-Farber Cancer Institute have discovered a mechanism of drug resistance to venetoclax, also known as ABT-199, a BCL-2 targeting drug commonly used to treat chronic lymphocytic leukemia and acute myeloid leukemia.
Edge Media Network/Associated Press - June 7
A hospital in Florida, the Moffitt Cancer Center, received 6,600 calls over 90 days faked to look as though they were coming from inside the hospital, diverting 65 hours of staff time from patient care.
Bicycling Training News - June 10
On that first day, doctors at Moffitt Cancer Center started running genetic tests to determine the type of leukemia and the course of action.
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.